Kidney Care Innovation: Medtech’s Next Frontier or Overhyped Trend?
The recent declaration by a medtech venture capital firm that kidney care is entering a new era of innovation is both timely and expected, but it warrants a critical lens.…
JPM26 Deal Activity Disappoints, But Signals Deeper Industry Shifts in Pharma and Medtech
The tepid dealmaking observed at JPM26 should not be mistaken for stagnation in the healthcare sector. Instead, it highlights a deeper recalibration as pharmaceutical companies brace for the impending patent…
The HMA/EMA AI Workshop: A Missed Opportunity for Proactive Industry Leadership
The upcoming HMA/EMA multi-stakeholder workshop on artificial intelligence, scheduled for November 2025, ostensibly promises a critical forum for dialogue among regulators, industry players, and other stakeholders. However, as a healthcare…
EMA’s Upcoming Webinar on New Variations Guidelines: A Critical Opportunity or Another Regulatory Tick-Box?
The European Medicines Agency’s announcement of a webinar on the new variations guidelines for marketing authorisation holders (human) scheduled for January 13, 2026, signals yet another regulatory update that healthcare…
EMA-EUCOPE Meeting: A Missed Opportunity for Meaningful Industry-Regulator Dialogue
The announcement of the fourth bilateral meeting between the European Medicines Agency (EMA) and the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) might seem routine, but it underscores a persistent challenge…
Fresenius CEO’s Call for a Healthcare ‘Fundamental Rethink’ Masks Deeper Industry Failures
Fresenius CEO’s remarks at Davos26 about the need for a “fundamental rethink” in healthcare delivery are less a visionary call to action and more a glaring indictment of how stagnant…
The Committee for Advanced Therapies: A Missed Opportunity for Industry Engagement in 2026
The announcement of the Committee for Advanced Therapies (CAT) meeting scheduled for January 21-23, 2026, at the European Medicines Agency in Amsterdam is, on the surface, a routine event in…
EMA’s Veterinary Medicines Info Day 2026: A Missed Opportunity for Industry Innovation and Engagement
The European Medicines Agency’s decision to host the Veterinary Medicines Info Day in a purely online format reflects both the evolving digital landscape and a cautious approach to stakeholder engagement.…
Passwordless Authentication: Healthcare IT’s Top Priority That Remains Elusive
The recent survey by Imprivata highlighting the enthusiasm among healthcare IT leaders for passwordless authentication is both unsurprising and deeply telling. It underscores a growing awareness that traditional password-based security…
EMA’s Upcoming Q&A Clinic Signals Growing Complexity in Regulatory Substance Management—Are Pharma Marketers Ready?
The European Medicines Agency’s decision to host a live Q&A clinic focused on Substance, Organisation, and Referential Management Services is more than a routine informational session—it’s a clear signal of…